Skip to main content

Table 2 Key barriers identified by stakeholder group and level of agreement

From: Patient’s access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal

Major research topic based on RA circuit

Key barriers identified

Level of agreement

U-GP

R-GP

REU

PHA

HMA

SPR

ANDAR

 

(n = 5)

(n = 5)

(n = 9)

(n = 6)

(n = 4)

(n = 1)

(n = 1)

Access to healthcare services

a) Difficulties in accessing primary healthcare services

0/5

3/5

NA

NA

NA

NA

NA

b) Difficulties in RA diagnosis among GPs

0/5

1/5

9/9

NA

NA

1/1

1/1

c) Difficulties in accessing secondary healthcare services

1/5

2/5

4/9

NA

NA

1/1

1/1

Treatment with biologics

d) Difficulties in accessing biologics

NA

NA

4/9

0/6

0/4

0/1

1/1

  1. Level of agreement: number of stakeholders who recognised the issue as a key barrier in the RA circuit/ total sample interviewed among the group of stakeholders, n: total sample interviewed among the group of stakeholders, NA: research topic not addressed by this group of stakeholders, RA: rheumatoid arthritis, GPs: general practitioners, U-GP: urban general practitioner, R-GP: rural general practitioner, REU: rheumatologist, PHA: hospital pharmacy managers and purchasers, HMA: hospital managers; SPR: Portuguese Society of Rheumatology, ANDAR: Rheumatoid Arthritis Patient Association.